» Articles » PMID: 37855057

Differential Transcriptional Control of Hematopoiesis in Congenital and Cyclic Neutropenia Patients Harboring Mutations

Abstract

Mutations in the ELANE gene, encoding the neutrophil elastase (NE) protein, are responsible for most cyclic neutropenia (CyN) cases and approximately 25% of congenital neutropenia (CN) cases. In CN and in CyN, a median of 2.8% of CD34+ cells were early CD49f+ hematopoietic stem cells (eHSC) that did not express ELANE and thus escape from the unfolded protein response (UPR) caused by mutated NE. In CyN, the CD49f+ cells respond to granulocyte colony-stimulating factor (G-CSF) with a significant upregulation of the hematopoietic stem cell-specific transcription factors, C/EBPα, MLL1, HOXA9, MEIS1, and HLF during the ascending arm of the cycle, resulting in the differentiation of myeloid cells to mature neutrophils at the cycle peak. However, NE protein released by neutrophils at the cycle's peak caused a negative feedback loop on granulopoiesis through the proteolytic digestion of G-CSF. In contrast, in CN patients, CD49f+ cells failed to express mRNA levels of HSC-specific transcription factors mentioned above. Rescue of C/EBPα expression in CN restored granulopoiesis.

Citing Articles

De Novo Deep Intron ELANE Mutation Resulting in Severe Congenital Neutropenia.

Shu Z, Deng M, Han T, Mao H J Clin Immunol. 2024; 44(8):183.

PMID: 39172268 DOI: 10.1007/s10875-024-01783-w.

References
1.
Argiropoulos B, Yung E, Humphries R . Unraveling the crucial roles of Meis1 in leukemogenesis and normal hematopoiesis. Genes Dev. 2007; 21(22):2845-9. DOI: 10.1101/gad.1619407. View

2.
Li F, Horwitz M . Characterization of mutant neutrophil elastase in severe congenital neutropenia. J Biol Chem. 2001; 276(17):14230-41. DOI: 10.1074/jbc.M010279200. View

3.
Fioredda F, Skokowa J, Tamary H, Spanoudakis M, Farruggia P, Almeida A . The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children: A Consensus Between the European Hematology Association and the EuNet-INNOCHRON COST Action. Hemasphere. 2023; 7(4):e872. PMC: 10065839. DOI: 10.1097/HS9.0000000000000872. View

4.
Ye M, Zhang H, Amabile G, Yang H, Staber P, Zhang P . C/EBPa controls acquisition and maintenance of adult haematopoietic stem cell quiescence. Nat Cell Biol. 2013; 15(4):385-94. PMC: 3781213. DOI: 10.1038/ncb2698. View

5.
Bonilla M, Dale D, Zeidler C, Last L, Reiter A, Ruggeiro M . Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. Br J Haematol. 1994; 88(4):723-30. DOI: 10.1111/j.1365-2141.1994.tb05110.x. View